Change and Constancy: The 2025 CLFS Update
The 2025 CLFS update—what has changed, what has stayed the same, and what that means for diagnostic test reimbursement in 2025
Funding-lir
Subscribe today for access to
Articles and Reports
Digital Health Fundraising Falls in 2022 but May Not Have Bottomed Out
According to a new report, tough macro-economic conditions caused digital health fundraising levels to fall off dramatically in 2022.
Digital Health Startup Fundraising Remains Robust Despite H1 2022 Declines
According to a recent report, digital health companies are on track to rake in $21 billion for 2022, below the 2021 total of $29.1 billion.
The Government Is Running Out of Money for COVID-19 Testing
The White House recently wrote that without restoring COVID-19 funding, the country won’t be able to buy enough supplies to combat the virus.
PAMA Unlocks Golden Age for Innovative Diagnostics
By Chance Scott bio
The publication of the 2018 Clinical Laboratory Fee Schedule (CLFS) in January saw a long and heated debate within the lab community come to fruition…
Kailos, Huntsman Institute Receive NIH Grant to Develop Cancer Recurrence Test
From - Laboratory Industry Report
The Alabama-based Kailos Genetics and the Huntsman Cancer Institute at the University of Utah have received a $2.4 million grant from the…
Quanterix Raises $46 Million to Fuel Expansion of Clinical Diagnostics
From - Laboratory Industry Report
A fresh infusion of capital is set to fuel continued growth at Quanterix Corporation (Lexington, Mass.), which specializes in "high-definition diagnostics" made possible by…
Sequenom Remakes Fiscal, Operational House
...
Already a member? Log in here
Sequenom Remakes Fiscal, Operational House
...
Already a member? Log in here
NantOmics Acquires OncoPlex Diagnostics
...
Already a member? Log in here
Exosome Raises Second Round Funding, Close to Launching Cancer Tests
...
Already a member? Log in here